Certified by Founder Lodge
Epigenic Therapeutics
China - Shanghai START UP
1 Disclosed Funding Rounds $32,000,000
0 Participating Investments
- Founded date
2021
- Operating Status
Active
- Last Funding Type
Seed
- Company Type
For Profit
- Website
- Contact
- Social Links
Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing regulation of epigenetic genome for a variety of diseases. Fou
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| August, 30 ,2023 | Series A | $32,000,000 |
OrbiMed
Qiming Venture Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Further AI | $5,000,000 | (Apr 3, 2025)
SchoolAI | $25,000,000 | (Apr 3, 2025)
Vivere | $7,500,000 | (Apr 3, 2025)
TrialKit | $4,250,000 | (Apr 3, 2025)
TwinKnowledge | $3,700,000 | (Apr 3, 2025)
